Santhera Receives Financing Commitment of up to CHF 20 Million from Fund Managed by Highbridge Capital Management
Transaction provides up to CHF 20.0 million in near-term liquidity Financing provides funding runway to advance DMD-franchise with Puldysa® and vamorolone
Read more